| MeSH term | MeSH ID | Detail |
|---|---|---|
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Fatty Liver | D005234 | 48 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Nervous System Diseases | D009422 | 37 associated lipids |
| Movement Disorders | D009069 | 3 associated lipids |
| Fever | D005334 | 35 associated lipids |
| Catalepsy | D002375 | 30 associated lipids |
| Death, Sudden | D003645 | 12 associated lipids |
| Tremor | D014202 | 15 associated lipids |
Decanoic acid
Decanoic acid is a lipid of Fatty Acyls (FA) class. Decanoic acid is associated with abnormalities such as Hashimoto Disease, Perisylvian syndrome, Parasitic Diseases, Acute myocardial infarction and Myocardial Infarction. The involved functions are known as Cell Differentiation process, Inflammation, Process, Subtraction process and Pressure- physical agent. Decanoic acid often locates in Epithelium, Tissue membrane, Body tissue, Membrane and Organelles. The associated genes with Decanoic acid are Genome, FATE1 gene, HTR3A wt Allele, FFAR1 gene and O3FAR1 gene. The related lipids are Membrane Lipids, Fatty Acids, Micelles, Stearic acid and rac-glycerol 1-monodecanoate.
Cross Reference
Introduction
To understand associated biological information of Decanoic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Decanoic acid?
Decanoic acid is suspected in Hashimoto Disease, Perisylvian syndrome, Parasitic Diseases, Acute myocardial infarction, Myocardial Infarction and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Science (1)
- Am. J. Physiol. Gastrointest. Liver Physiol. (1)
- Am. J. Physiol. Heart Circ. Physiol. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Decanoic acid
PubChem Associated disorders and diseases
What pathways are associated with Decanoic acid
Lipid pathways are not clear in current pathway databases. We organized associated pathways with Decanoic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Decanoic acid?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Decanoic acid?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Decanoic acid?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Decanoic acid?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Decanoic acid?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Decanoic acid
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Falloon I et al. | The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine. | 1978 | Psychol Med | pmid:418431 |
| Müller P et al. | [Pharmacogenic depressive syndromes in the course of schizophrenic psychoses (author's transl)]. | 1978 | Arzneimittelforschung | pmid:383099 |
| Chen PC | [Pharmacological studies of long-acting phenothiazines with particular reference to fluphenazine decanoate (author's transl)]. | 1978 | Nippon Yakurigaku Zasshi | pmid:570538 |
| Marriott P and Hiep A | Drug monitoring at an Australia depot phenothiazine clinic. | 1978 | J Clin Psychiatry | pmid:580271 |
| Iqbal MJ et al. | A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients. | 1978 | J Clin Psychiatry | pmid:580285 |
| MacCrimmon DJ et al. | Fluphenazine decanoate and fluphenazine enanthate in the out-patient management of chronic schizophrenia. | 1978 | Neuropsychobiology | pmid:692838 |
| Franklin M et al. | Sensitive gas-chromatographic determination of fluphenazine in human plasma. | 1978 | Clin. Chem. | pmid:618664 |
| Levin BC and Freese E | Cell binding and growth inhibition by hexachlorophene of decanoate and their reversibility. | 1978 | J Environ Sci Health C | pmid:96167 |
| Quitkin F et al. | Long-acting oral vs injectable antipsychotic drugs in schizophrenics: a one-year double-blind comparison in multiple episode schizophrenics. | 1978 | Arch. Gen. Psychiatry | pmid:98127 |
| Rifkin A et al. | Fluphenazine decanoate, fluphenazine hydrochloride given orally, and placebo in remitted schizophrenics. I. Relapse rates after one year. | 1977 | Arch. Gen. Psychiatry | pmid:189724 |
| Rifkin A et al. | Fluphenazine decanoate, oral fluphenazine, and placebo in treatment of remitted schizophrenics. II. Rating scale data. | 1977 | Arch. Gen. Psychiatry | pmid:199129 |
| Rifkin A et al. | Fluphenazine decanoate, oral fluphenazine, and placebo in the treatment of remitted schizophrenics. II. Rating scale data [proceedings]. | 1977 | Psychopharmacol Bull | pmid:323910 |
| Mindham RH et al. | A comparison of piribedil, procyclidine and placebo in the control of phenothiazine-induced parkinsonism. | 1977 | Br J Psychiatry | pmid:326325 |
| Quitkin F et al. | A one-year double-blind comparison of long-acting oral (penfluridol) versus long-acting injectable (fluphenazine decanoate) antipsychotic drugs in multiple-episode schizophrenics. | 1977 | Psychopharmacol Bull | pmid:329327 |
| Kelly HB et al. | Clinical and social comparison of fluphenazine decanoate and flupenthixol decanoate in the community maintenance therapy of schizophrenia. | 1977 | Int Pharmacopsychiatry | pmid:406212 |
| Lemberger L et al. | The effect of L-dopa and lergotrile mesylate on the interaction of fluphenazine decanoate and amphetamine-induced stereotypy and mortality. | 1977 | Commun Psychopharmacol | pmid:564259 |
| Ginestet D et al. | ["Heat stroke" and/or "Malin's syndrome" in a patient treated with fluphenazine decanoate]. | 1977 | Encephale | pmid:611015 |
| Nowycky MC and Roth RH | Presynaptic dopamine receptors. Development of supersensitivity following treatment with fluphenazine decanoate. | 1977 | Naunyn Schmiedebergs Arch. Pharmacol. | pmid:600312 |
| Obretenov T and Hadjieva P | [Gas-chromatographic-mass-spectral analysis of aroma-compounds of bread (author's transl)]. | 1977 | Z Lebensm Unters Forsch | pmid:602439 |
| Cleary MF | Fluphenazine decanoate during pregnancy. | 1977 | Am J Psychiatry | pmid:869065 |
| Woggon B et al. | [Comparison of the effects of pipothiazine palmitate and fluphenazine decanoate. Results of a multicenter double-blind trial]. | 1977 | Int Pharmacopsychiatry | pmid:22515 |
| Stevens B | The social value of fluphenazine decanoate. | 1976 Sep-Oct | Acta Psychiatr Belg | pmid:799897 |
| Terrence CF | Fluphenazine decanoate in the treatment of chorea: a double-blind study. | 1976 | Curr Ther Res Clin Exp | pmid:133787 |
| Johnson KG et al. | Studies on the cellular and free lipopolysaccharides from Branhamella catarrhalis. | 1976 | Can. J. Microbiol. | pmid:1260539 |
| Dreyfuss J et al. | Fluphenazine enanthate and fluphenazine decanoate: intramuscular injection and esterification as requirements for slow - release characteristics in dogs. | 1976 | J Pharm Sci | pmid:966144 |
| Orr MW and Boullin DJ | The ralationship between changes in 5-HT induced platelet aggregation and clinical state in patients treated with fluphenazine. | 1976 | Br J Clin Pharmacol | pmid:973988 |
| Tjaden UR et al. | Anodic coulometric detection with a glassy carbon electrode in combination with reversed-phase high-performance liquid chromatography. Determination of blood levels of perphenazine and fluphenazine. | 1976 | J. Chromatogr. | pmid:977680 |
| Polonowita A and James NM | Fluphenazine decanoate maintenance in schizophrenia: a retrospective study. | 1976 | N. Z. Med. J. | pmid:1066554 |
| Caffier G et al. | [Influence of homologous n-alkanoic on functional properties of isolated skeletal muscles. II. Membrane resting potential and the osmotic effectiveness of alkanoic acid]. | 1976 | Acta Biol. Med. Ger. | pmid:1035456 |
| Idzorek S | Antiparkinsonian agents and fluphenazine decanoate. | 1976 | Am J Psychiatry | pmid:1247126 |
| Schooler NR and Levine J | The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine. | 1976 | Pharmakopsychiatr Neuropsychopharmakol | pmid:790413 |
| Capstick N and Pudney H | A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy. | 1976 | J. Int. Med. Res. | pmid:800383 |
| Rifkin A et al. | Comparison of fluphenazine decanoate, oral fluphenazine, and placebo in remitted outpatient schizophrenics. | 1976 | Psychopharmacol Bull | pmid:769022 |
| McClelland HA et al. | Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia. | 1976 | Arch. Gen. Psychiatry | pmid:11760 |
| Whelpton R and Curry SH | Methods for study of fluphenazine kinetics in man. | 1976 | J. Pharm. Pharmacol. | pmid:12260 |
| Freeman H | Letter: Fluphenazine decanoate. | 1976 | Lancet | pmid:54532 |
| Letter: Fluphenazine decanoate. | 1976 | Lancet | pmid:54770 | |
| Lamb P et al. | Letter: Parkinsonism induced by fluphenazine decanoate. | 1976 | Lancet | pmid:55747 |
| Carney MW | Letter: Fluphenazine decanoate. | 1976 | Lancet | pmid:55828 |
| Verhaegen JJ | The long-term use of high doses of fluphenazine enanthate and fluphenazine decanoate. | 1975 Jul-Aug | Compr Psychiatry | pmid:1157479 |
| Christodoulidis H and Frangos H | Clinical experience with fluphenazine decanoate in the treatment of patients with long-standing chronic schizophrenia. | 1975 | Curr Ther Res Clin Exp | pmid:809234 |
| Groves JE and Mandel MR | The long-acting phenothiazines. | 1975 | Arch. Gen. Psychiatry | pmid:239663 |
| Dreyfuss J et al. | Depot fluphenazine enanthate and decanoate: comparative rates of release in dogs. | 1975 | J. Pharm. Pharmacol. | pmid:241800 |
| Marcjan K et al. | [Results of the use of fluphenazine in a depot preparation]. | 1975 | Psychiatr Neurol Med Psychol Beih | pmid:829619 |
| Haslam MT et al. | A comparative trail of fluphenazine decanoate and flupenthixol decanoate. | 1975 | Acta Psychiatr Scand | pmid:1091124 |
| Johnson DA and Malik NA | A double-blind comparison of fluphenazine decanoate and flupenthixol decanoate in the treatment of acute schizophrenia. | 1975 | Acta Psychiatr Scand | pmid:1096536 |
| Corbett L | Technique of fluphenazine decanoate therapy in acute schizophrenic illnesses. | 1975 | Dis Nerv Syst | pmid:1164860 |
| Fay JP and Farias RN | The inhibitory action of fatty acids on the growth of Escherichia coli. | 1975 | J. Gen. Microbiol. | pmid:1107472 |
| Johnson DA | Observations on the dose regime of fluphenazine decanoate in maintenance therapy ofschizophrenia. | 1975 | Br J Psychiatry | pmid:1125521 |
| Marriott P et al. | Letter: Flexibility in the use of fluphenazine decanoate. | 1975 | Br J Psychiatry | pmid:1131475 |
| Giselmann A et al. | [Letter: Heart conduction disorders and fluphenazine decanoate]. | 1975 | Nouv Presse Med | pmid:1134934 |
| Mazliak P et al. | [Decanoic acid, new precursor for in vitro biosynthesis of oleic acid by a plant subcellular fraction]. | 1975 | Biochimie | pmid:4158 |
| La Mura G et al. | [Treatment of psychoses with a long-acting neuroleptic agent (fluphenazine decanoate). Clinico-psychopathological study of 53 patients]. | 1974 Jul-Aug | Acta Neurol (Napoli) | pmid:4615572 |
| Martin IC and Townend RA | Implications of sustained release phenothiazines: a study of fluphenazine decanoate. | 1974 | Br J Psychiatry | pmid:4596672 |
| Simpson RB et al. | Partition of fatty acids. | 1974 | J. Lipid Res. | pmid:4853545 |
| Chandra O et al. | Long-term trial of fluphenazine decanoate and flupenthixol decanoate for cataleptic activity and effect on motor activity in rats. | 1974 | Arzneimittelforschung | pmid:4480057 |
| Yew D | Management of schizophrenic patients on fluphenazine decanoate. | 1974 | Nurs J Singapore | pmid:4498541 |
| Small JG and Kellams J | Early hospital experience with fluphenazine decanoate. | 1974 | Dis Nerv Syst | pmid:17894058 |
| Timm U and Pfeifer S | [Assay and determination of fluphenazine decanoate in oily solution]. | 1973 Nov-Dec | Pharmazie | pmid:4791276 |
| Adamson L et al. | Fluphenazine decanoate trial in chronic in-patient schizophrenics failing to absorb oral chlorpromazine. | 1973 Apr-May | Dis Nerv Syst | pmid:4711886 |
| Dencker SJ et al. | A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial. | 1973 | Acta Psychiatr Scand Suppl | pmid:4147508 |
| Winter K et al. | A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia. | 1973 | Br J Clin Pract | pmid:4601614 |
| Hirsch SR et al. | Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: double-blind placebo trial. Report to the Medical Research Council Committee on Clinical Trials in Psychiatry. | 1973 | Br Med J | pmid:4571196 |
| van Praag HM and Dols LC | Fluphenazine enanthate and fluphenazine decanoate: a comparison of their duration of action and motor side effects. | 1973 | Am J Psychiatry | pmid:4576449 |
| Stevens BC | Role of fluphenazine decanoate in lessening the burden of chronic schizophrenics on the community. | 1973 | Psychol Med | pmid:4577254 |
| Johnson DA | The side-effects of fluphenazine decanoate. | 1973 | Br J Psychiatry | pmid:4766647 |
| Curry SH and Adamson L | Double-blind trial of fluphenazine decanoate. | 1972 | Lancet | pmid:4115602 |
| Martin A et al. | [Comparative study of the action of fluphenazine oenanthate and decanoate in chronic psychoses (73 cases)]. | 1972 | Ann Med Psychol (Paris) | pmid:4576210 |
| Evrard E et al. | [Action of flupentixol decanoate in chronic psychoses of the schizophrenic type]. | 1972 | Acta Psychiatr Belg | pmid:4669430 |
| Kabara JJ et al. | Fatty acids and derivatives as antimicrobial agents. | 1972 | Antimicrob. Agents Chemother. | pmid:4670656 |
| Grozier ML | Why a long-acting neuroleptic? Fluphenazine decanoate. (Brief review and clinical rationale). | 1971 Jan-Feb | Psychosomatics | pmid:5545629 |
| Denham J and Adamson L | The contribution of fluphenazine enanthate and decanoate in the prevention of readmission of schizophrenic patients. | 1971 | Acta Psychiatr Scand | pmid:4336483 |
| Kinzie JD and Simons RC | Outpatient treatment of psychotic patients with a long-acting phenothiazine: fluphenazine decanoate. | 1971 | Med J Malaya | pmid:4260859 |
| Keskiner A et al. | EEG changes after fluphenazine enanthate and decanoate based on analog power spectra and digital computer period analysis. | 1971 | Psychopharmacologia | pmid:5565254 |
| BLOMSTRAND R | Transport form of decanoic acid-1-14C in the lymph during intestinal absorption in the rat. | 1955 | Acta Physiol. Scand. | pmid:13258301 |
| HANSEN RP and COOKE NJ | The occurrence of n-decanoic acid in mutton fat. | 1953 | Biochem. J. | pmid:13058823 |
| Thirugnanasampanthan U et al. | Reversible cerebral atrophy: a case report and literature review. | Gen Hosp Psychiatry | pmid:16950389 | |
| Stuyt EB et al. | Differing effects of antipsychotic medications on substance abuse treatment patients with co-occurring psychotic and substance abuse disorders. | Am J Addict | pmid:16595355 | |
| pmid:6613612 | ||||
| Llorca PM et al. | [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. | Encephale | pmid:15959450 | |
| pmid:26129951 | ||||
| Won K and Lee SB | Computer-aided control of water activity for lipase-catalyzed esterification in solvent-free systems. | Biotechnol. Prog. | pmid:11312702 | |
| pmid:21954937 | ||||
| pmid: | ||||
| pmid:16466902 | ||||
| Tateoka R et al. | Significance of substrate hydrophobicity for recognition by an oligopeptide transporter (PEPT1). | Bioconjug. Chem. | pmid:11459451 | |
| Zhang S et al. | Influence of pulsed electric field treatments on the volatile compounds of milk in comparison with pasteurized processing. | J. Food Sci. | pmid:21535640 | |
| Liu PY et al. | Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome. | Gen Hosp Psychiatry | pmid:21353143 | |
| Choi MH et al. | First-order kinetics analysis of monomer composition dependent polyhydroxyalkanoic acid degradation in Pseudomonas spp. | Biomacromolecules | pmid:12625741 | |
| pmid:21360616 |